Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Equity (2016 - 2025)

AC Immune has reported Return on Equity over the past 9 years, most recently at 0.01% for Q4 2025.

  • Quarterly Return on Equity fell 1.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, down 1.0% year-over-year, with the annual reading at 0.01% for FY2025, 1.0% down from the prior year.
  • Return on Equity was 0.01% for Q4 2025 at AC Immune, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q2 2021 and troughed at 0.01% in Q4 2025.
  • The 5-year median for Return on Equity is 0.0% (2022), against an average of 0.0%.
  • Year-over-year, Return on Equity changed 0bps in 2021 and then decreased -1bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then crashed by -48730bps to 0.0% in 2022, then increased by 7bps to 0.0% in 2023, then decreased by -11bps to 0.0% in 2024, then tumbled by -206bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Return on Equity are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).